Pronóstico del mercado de radiofármacos de Oriente Medio y África hasta 2028: impacto de COVID-19 y análisis regional por tipo (medicina nuclear de diagnóstico y medicina nuclear terapéutica), aplicación (oncología, cardiología, neurología y otros) y usuario final (hospitales, centros de imágenes, Centros Académicos y de Investigación, y Otros)

Introducción al mercado

El mercado de radiofármacos de MEA se analiza en función de Arabia Saudita, los Emiratos Árabes Unidos, Sudáfrica y el resto de MEA. Arabia Saudita es uno de los mercados más grandes de la región. La prevalencia de accidentes cerebrovasculares ha aumentado significativamente en el Reino de Arabia Saudita (KSA), convirtiéndose en una causa importante de enfermedad y muerte en Arabia Saudita. Sin embargo, la investigación sobre la incidencia, prevalencia y propiedades sociodemográficas del accidente cerebrovascular aún es inadecuada en comparación con los países desarrollados. Se espera que la falta de conciencia se deba a la falta de estudios apropiados que se estén realizando en estas áreas específicas. El accidente cerebrovascular es un problema que aumenta rápidamente en Arabia Saudita y es una de las principales causas de enfermedad y muerte. Sin embargo, en comparación con los países desarrollados, todavía faltan investigaciones sobre la incidencia, la prevalencia y las características sociodemográficas del accidente cerebrovascular debido a la falta de estudios adecuados en estas áreas. Entre los árabes, un gran porcentaje de los factores de riesgo de accidente cerebrovascular son factores modificables bien conocidos, como la hipertensión y la diabetes. El riesgo de morir por un derrame cerebral aumenta con la edad y el riesgo de morir por una hemorragia cerebral es mayor. Los accidentes cerebrovasculares en jóvenes representan entre el 6 y el 20 % de todos los accidentes cerebrovasculares. Debido al aumento de las instalaciones relacionadas con los radiofármacos y la creciente prevalencia de enfermedades crónicas, se prevé que el mercado de radiofármacos en la región MEA experimente un crecimiento significativo durante el período de pronóstico.

En caso de COVID-19, MEA se ve muy afectada especialmente Sudáfrica. Los países de Medio Oriente también han afectado ampliamente su condición socioeconómica por la pandemia de COVID-19. Sin embargo, los países han reaccionado sabiamente ante la pandemia de COVID-19 para evitar la propagación de la infección. Al igual que en otras regiones, se impusieron confinamientos y distanciamiento social, lo que perjudicó estas tendencias y obstaculizó el acceso al trabajo, ingresos regulares, pagos, ferias, escuelas y atención médica. Por tanto, se espera que los países hayan sufrido enormes pérdidas y todavía estén intentando recuperarlas. El bloqueo ha afectado ampliamente a los servicios médicos que no son de emergencia en la región, afectando a los dispositivos médicos. Países como Arabia Saudita y los Emiratos Árabes Unidos están surgiendo como destinos de atención médica en las regiones. Sin embargo, dependen de los países para obtener los recursos. Se espera que la disponibilidad de vacunas y otros servicios sanitarios en los países en desarrollo de la región proporcionen margen para el mercado en unos años. La pandemia de COVID-19 ha ayudado a los países antes mencionados a mejorar su capacidad y mostrar sus capacidades en materia de servicios de salud. En Arabia Saudita, el número de visitas por problemas neurológicos comunes disminuyó en un 24 por ciento. En comparación con la prepandemia, durante todo el período de la pandemia. El ejemplo más notable son las tomografías computarizadas del cerebro, que aumentaron un 11,3 por ciento durante el período epidémico. Una de las principales causas de la disminución de las visitas a los servicios de urgencias es el miedo a contraer la infección por COVID-19 con solo visitar los hospitales. Es probable que estos factores tengan un impacto negativo en el crecimiento del mercado.

Descripción general y dinámica del mercado

Se espera que el mercado de radiofármacos de MEA crezca de 381,20 millones de dólares en 2021 a 639,78 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 7,7% de 2021 a 2028. El uso de procedimientos de medicina nuclear se está expandiendo rápidamente, a medida que la PET y la SPECT continúan mejorando la precisión de la detección, localización y caracterización de enfermedades. La PET y la SPECT se encuentran entre las modalidades de radiología de medicina nuclear empleadas en entornos clínicos. Según la Sociedad de Medicina Nuclear, cada año se realizan millones de procedimientos de medicina nuclear con radiofármacos e instrumentos de imágenes para diagnosticar enfermedades y administrar tratamientos específicos en los países de la región. Estas técnicas también se han adoptado en inmunología, infecciones, gastroenterología, cardiología, oncología, neurología y psiquiatría, entre otros campos, para diagnóstico y otras aplicaciones. Las medicinas nucleares avanzadas y los modernos equipos de imágenes están ayudando a los médicos a diagnosticar enfermedades de mejor manera y en menos tiempo. El desarrollo continuo de nuevos radiofármacos para las plataformas PET/CT y SPECT/CT, que se utilizan en aplicaciones clínicas novedosas como neurología y ortopedia, junto con la precisión cada vez mayor de los diferentes métodos de estadificación de tumores, están contribuyendo aún más al crecimiento del mercado. En septiembre de 2020, Curium lanzó Detectnet, un agente de tomografía por emisión de positrones (PET), indicado para la localización de tumores neuroendocrinos (TNE) positivos para receptores de somatostatina en pacientes adultos. Por lo tanto, los avances tecnológicos para mejorar la calidad y eficacia de las técnicas de imágenes nucleares están favoreciendo el crecimiento del mercado de radiofármacos MEA.

Segmentos clave del mercado

En términos de tipo, el segmento de medicina nuclear de diagnóstico representó la mayor participación del mercado de radiofármacos de MEA en 2020. En términos de aplicación, el segmento de oncología tuvo una mayor participación de mercado del mercado de radiofármacos de MEA en 2020. Además, el segmento de hospitales tuvo una mayor participación en el mercado de radiofármacos de MEA según el usuario final en 2020.

Principales fuentes y empresas cotizadas

Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el mercado de radiofármacos de MEA son los sitios web de las empresas, los informes anuales, los informes financieros, los documentos del gobierno nacional y las bases de datos estadísticas, entre otros. Las principales empresas que figuran en el informe son Advanced Accelerator Applications, Bayer AG, Bracco Imaging SpA, Cardinal Health Inc, Curium, ECZACIBA?I MONROL NUCLEAR PRODUCTS CO., GENERAL ELECTRIC, Nordion y NTP RADIOISOTOPES.

Informe de razones para comprar

Comprender el panorama del mercado de radiofármacos de MEA e identificar los segmentos de mercado que tienen más probabilidades de garantizar un fuerte rendimiento
Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio del mercado de radiofármacos de MEA
Planifique eficientemente fusiones y adquisiciones y acuerdos de asociación en el mercado de radiofármacos de MEA identificando segmentos de mercado con las ventas probables más prometedoras
Ayuda a tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo del desempeño del mercado de varios segmentos formar el mercado de radiofármacos MEA
Obtener pronóstico de ingresos de mercado para varios segmentos de 2021 a 2028 en la región MEA.

Segmentación del mercado de radiofármacos MEA

Mercado de radiofármacos MEA - Por tipo

Medicina nuclear de diagnóstico
- SPECT
- PET
Medicina Nuclear Terapéutica
- Emisores Alfa
- Emisores Beta
- Isótopos de Braquiterapia

< p>Mercado de radiofármacos MEA - Por aplicación

Oncología
Cardiología
Neurología
Otros

Mercado de radiofármacos MEA - Por usuario final

Hospitales
Centros de imágenes
Centros académicos y de investigación ;
Otros

Mercado de radiofármacos MEA: por país

Arabia Saudita
Sudáfrica
EAU
Resto de MEA

Mercado de radiofármacos MEA: perfiles de empresas

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Radiopharmaceuticals Market – By Type

1.3.2 MEA Radiopharmaceuticals Market – By Application

1.3.3 MEA Radiopharmaceuticals Market – By End User

1.3.4 MEA Radiopharmaceuticals Market– By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Radiopharmaceuticals Market– Market Landscape

4.1 Overview

4.2 MEA PEST Analysis

4.3 Experts Opinion

5. MEA Radiopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Escalation in the Usage of Alpha Radio Immunotherapy

5.1.2 Surging Advancements in Nuclear Imaging Techniques

5.2 Market Restraints

5.2.1 Accessibility of Substitutes

5.3 Market Opportunities

5.3.1 Growth Potential in Several Countries

5.4 Future Trends

5.4.1 Burgeoning Usage of Nuclear Medicines for Personalized Treatment

5.5 Impact Analysis

6. Radiopharmaceuticals Market– MEA Analysis

6.1 MEA Radiopharmaceuticals Market Revenue Forecast and Analysis

7. MEA Radiopharmaceuticals Market Analysis – By Type

7.1 Overview

7.2 MEA Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Nuclear Medicine

7.3.1 Overview

7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 SPECT

7.3.3.1 Overview

7.3.3.2 SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 PET

7.3.4.1 Overview

7.3.4.2 PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Therapeutic Nuclear Medicine

7.4.1 Overview

7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Alpha Emitters

7.4.3.1 Overview

7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Beta Emitters

7.4.4.1 Overview

7.4.4.2 Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Brachytherapy Isotopes

7.4.5.1 Overview

7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8. MEA Radiopharmaceuticals Market Analysis – By Application

8.1 Overview

8.2 MEA Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

8.3 Oncology

8.3.1 Overview

8.3.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Cardiology

8.4.1 Overview

8.4.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Neurology

8.5.1 Overview

8.5.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9. MEA Radiopharmaceuticals Market Analysis – By End User

9.1 Overview

9.2 MEA Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Imaging Centres

9.4.1 Overview

9.4.2 Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Centers

9.5.1 Overview

9.5.2 Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10. MEA Radiopharmaceuticals Market – Country Analysis

10.1 MEA: Radiopharmaceuticals Market

10.1.1 Overview

10.1.2 MEA: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

10.1.2.1 Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1 Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2 Saudi Arabia Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1 Saudi Arabia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.2.2 Saudi Arabia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.3 Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4 Saudi Arabia Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.2 UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1 UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2 UAE Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1 UAE: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.2.2 UAE a: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.3 UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4 UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.3 South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1 South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2 South Africa Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1 South Africa: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.2.2 South Africa: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.3 South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4 South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.4 Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1 Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.2 Rest of MEA Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2.1 Rest of MEA: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.2.2 Rest of MEA: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.3 Rest of MEA Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4 Rest of MEA Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

11. Impact Of COVID-19 Pandemic on MEA Radiopharmaceuticals Market

11.1 MEA: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Inorganic Growth Strategies

12.2.1 Overview

12.3 Organic Growth Strategies

12.3.1 Overview

13. Company Profiles

13.1 Cardinal Health Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Curium

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GENERAL ELECTRIC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Bayer AG

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Bracco Imaging S.p.A

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Nordion

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 NTP RADIOISOTOPES

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Advanced Accelerator Applications

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. MEA Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Table 2. Saudi Arabia Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3. Saudi Arabia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 4. Saudi Arabia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 5. Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 6. Saudi Arabia Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7. UAE Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8. UAE Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 9. UAE Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 10. UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 11. UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. South Africa Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 13. South Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 14. South Africa Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 15. South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 16. South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17. Rest of MEA Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 18. Rest of MEA Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 19. Rest of MEA Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 20. Rest of MEA Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of MEA Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 22. Recent Inorganic Growth Strategies

Table 23. Recent Organic Growth Strategies

Table 24. Glossary of Terms

LIST OF FIGURES

Figure 1. MEA Radiopharmaceuticals Market Segmentation

Figure 2. MEA Radiopharmaceuticals Market Segmentation, By Country

Figure 3. MEA Radiopharmaceuticals Market Overview

Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021

Figure 5. Saudi Arabia to Show Significant Growth During Forecast Period

Figure 6. MEA PEST Analysis

Figure 7. MEA Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints

Figure 8. MEA Radiopharmaceuticals Market– Revenue Forecast and Analysis

Figure 9. MEA Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

Figure 10. MEA Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. MEA SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. MEA PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. MEA Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. MEA Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. MEA Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. MEA Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. MEA Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

Figure 18. MEA Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. MEA Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. MEA Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. MEA Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. MEA Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)

Figure 23. MEA Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. MEA Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. MEA Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. MEA Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. MEA: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. MEA: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 29. Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30. UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32. Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33. Impact of COVID-19 Pandemic in MEA Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA radiopharmaceuticals market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the MEA radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the radiopharmaceuticals market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S..	May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En..	May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample